Genetic Profile and Treatment of NSCLC
We recommend
Lorlatinib in a Patient with Meningeal Carcinomatosis – Case Report
The prognosis of patients with meningeal carcinomatosis is unfavorable. The following case report demonstrates how a targeted mechanism of action and optimal drug penetration into the central nervous system (CNS) can not only quickly relieve patients from neurological problems associated with meningeal infiltration, but also prolong their survival.
Complete remission of ALK-positive lung cancer in a patient after multiple lines of targeted therapy – a case study
Targeted treatment for driving oncogenic mutations has significantly improved outcomes for patients…
Lorlatinib as an Alternative to CNS Radiotherapy in Patients with NSCLC − Case Studies
Two remarkable case studies from authors at the Netherlands Cancer Institute Antoni van Leeuwenhoek…
No content is currently available on this topic.
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- Lorlatinib in a Patient with Meningeal Carcinomatosis – Case Report
- Lorlatinib as an Alternative to CNS Radiotherapy in Patients with NSCLC − Case Studies
- Complete remission of ALK-positive lung cancer in a patient after multiple lines of targeted therapy – a case study
Journal on this topic
Related topic